Ratnakar Securities Pvt. Ltd.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE4899.45112.85 (+2.36 %)

PREV CLOSE ( ) 4786.60

OPEN PRICE ( ) 4879.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1450

TODAY'S LOW / HIGH ( )4767.70 4930.00

52 WK LOW / HIGH ( )3211.05 5519.1

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-08 1973

Management Info

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

28Mar USFDA concludes inspection at Alkem La
U.S Food and Drug Administration (USFDA) has concluded inspection at Alk..

28Mar Alkem Laboratories incorporates wholly
Alkem Laboratories has incorporated Wholly Owned Subsidiary (WOS) of the..

06Mar Alkem Laboratories informs about notic
Alkem Laboratories has informed that it attached the Postal Ballot Notic..

28Feb USFDA issues EIR for Alkem Laboratorie
U.S Food and Drug Administration (USFDA) has issued an Establishment Ins..

28Feb Alkem Laboratories informs about press
In furtherance to the intimation captioned â€˜US FDA Inspection at Compa..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	5042.3	11344.7
Gross Profit	5343.8	13269.9
Operating Profit	6649.2	16432.4
Net Sales	24945.9	90545.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60
Jenburkt Pharma (BSE) 840.85 (4.94%)	M.Cap ( in Cr)371.09

Shareholding Pattern

	PROMOTERS	56.74%
	FI/BANKS/INSURANCE	2.75%
	NON-INSTITUTION	18.52%
	MUTUAL FUNDS/UTI	11.92%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Kotak Healthcare Fu...	4.35
DSP Midcap Fund-Reg(G)	4.05
LIC MF Healthcare F...	3.87
Tata India Pharma &...	3.83
ICICI Pru Nifty Pha...	3.80
Nippon India Nifty ...	3.80

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

ALKEM LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES